Some studies have testified that activation or attenuation of MAPK modulates cardiac energy metabolism through the Sirt1 pathway, thus mitigating or aggravating myocardial hypertrophy [39,40]. The gene discussed is SIRT1; the disease is cardiac hypertrophy.